StoneCastle Financial (NASDAQ:BANX) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.46 by 8.7 percent. This is a 5 percent increase over earnings of $0.40 per share from the same period last year.
Raymond James Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $33
Raymond James analyst Steven Seedhouse maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $34 to $33.